Shares in Stratagene rose 22.4 percent over the five-day trading period ended Tuesday, far outgaining any of the other stocks that comprise the BCW Index. The gain is likely the result of investors believing that a recent sell off was unwarranted. Two weeks ago, the firm's shares dropped nearly 19 percent on news that a jury found the firm had willfully infringed patents held by Third Wave Technologies and ordered Stratagene to pay damages of $5.3 million (see BioCommerce Week 9/8/2005).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.